315 related articles for article (PubMed ID: 20359630)
1. Innate immune signaling in the myelodysplastic syndromes.
Starczynowski DT; Karsan A
Hematol Oncol Clin North Am; 2010 Apr; 24(2):343-59. PubMed ID: 20359630
[TBL] [Abstract][Full Text] [Related]
2. Deconstructing innate immune signaling in myelodysplastic syndromes.
Varney ME; Melgar K; Niederkorn M; Smith M; Barreyro L; Starczynowski DT
Exp Hematol; 2015 Aug; 43(8):587-598. PubMed ID: 26143580
[TBL] [Abstract][Full Text] [Related]
3. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
4. Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.
Trowbridge JJ; Starczynowski DT
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 34129017
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
8. Molecular bases of myelodysplastic syndromes: lessons from animal models.
Komeno Y; Kitaura J; Kitamura T
J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
[TBL] [Abstract][Full Text] [Related]
9. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
11. The role of colony stimulating factors in leukaemogenesis.
Griffin JD; Young DC
Clin Haematol; 1986 Nov; 15(4):995-1002. PubMed ID: 3032485
[No Abstract] [Full Text] [Related]
12. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of microRNAs in myelodysplastic syndrome.
Rhyasen GW; Starczynowski DT
Leukemia; 2012 Jan; 26(1):13-22. PubMed ID: 21852786
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
15. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes: the pediatric point of view.
Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
[TBL] [Abstract][Full Text] [Related]
17. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.
Gañán-Gómez I; Wei Y; Starczynowski DT; Colla S; Yang H; Cabrero-Calvo M; Bohannan ZS; Verma A; Steidl U; Garcia-Manero G
Leukemia; 2015 Jul; 29(7):1458-69. PubMed ID: 25761935
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.
Kerkhoff N; Bontkes HJ; Westers TM; de Gruijl TD; Kordasti S; van de Loosdrecht AA
Immunotherapy; 2013 Jun; 5(6):621-37. PubMed ID: 23725285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
